clinical neuropsychology: a pocket handbook for assessment

Fully revised and updated, this pocket handbook for clinical assessment covers a comprehensive range of neurological, neuropsychological, neuropsychiatric, and neurobehavioral syndromes and disorders.

Now in its fourth edition, this ready reference helps the busy clinician or doctoral-level trainee select from among hundreds of tests and assessment techniques in clinical neuropsychology. It guides clinicians in developing tailored, hypothesis-driven approaches for assessing patients with a broad range of common neuropsychological syndromes and neurological disorders.

This book is an invaluable diagnostic guide designed to fit into a lab coat pocket for accessible and immediate use.

Major updates to the new edition include:

• A revamped approach to contemporary neuropsychological assessment that incorporates cultural factors, mood, emotion and affect, medications, cognitive functioning and electrophysiology data, as well as emerging trends including tele-neuropsychology, positive neuropsychology, and consumer-focused reports.
• New and expanded coverage of topics including updates on neurodegenerative disorders and mild cognitive impairment (MCI); lifestyle interventions to maximize cognitive functioning in MCI and dementia; chronic traumatic encephalopathy (CTE), autoimmune disorders, and motor disorders.
• An increased emphasis on neuropsychiatric syndromes. New topics include intellectual disabilities, the impact of marijuana and alcohol on cognitive functioning, anxiety disorders/PTSD, and an expanded focus on mood disorders.
• Updated online resources to support teaching and learning through neuroimaging figures and video demonstrations of exam techniques, and extended reading lists that have been expanded and more fully integrated into assessment chapters.

Michael W. Parsons, PhD, ABPP, is a clinical neuropsychologist in the Pappas Neuro-Oncology Center and Department of Psychiatry at Massachusetts General Hospital. His clinical and research activities focus on the cognitive and behavioral consequences of cancer, including brain tumors and non-central nervous system cancers. He is the author of numerous peer reviewed manuscripts and book chapters related to these issues and serves as the copresident of the neuro-oncology special interest group of the International Neuropsychological Society. Dr. Parsons is a diplomate of the American Board of Clinical Neuropsychology and the American Board of Professional Psychology.

Michelle M. Braun, PhD, earned her Master of Science and PhD in clinical psychology with a minor in neuroscience from the University of Wisconsin-Milwaukee. Dr. Braun has worked for 15 years as a clinical neuropsychologist in departments of neurology, neurosurgery, and psychiatry in hospitals and academia. She serves as an examiner for the American Board of Clinical Neuropsychology, and is a previous board member of the board of directors of the American Academy of Clinical Neuropsychology, where she chaired the Practice and Public Policy Committee. She is also a previous member of the board of directors of the Wisconsin Psychological Association.